Management provides a clinical update from the Phase 1/2 ABILITY Study on a conference call to be held on August 9 at 8:30 am. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MDNA:
- Medicenna Therapeutics completes MDNA11 dose escalation
- Medicenna Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study
- Medicenna Therapeutics to host conference call
- Medicenna Therapeutics appoints Yavari as Chair of DAC
- Medicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee